抗VEGF治疗糖尿病黄斑水肿的长期视力结局与形态学生物标志物
该回顾性队列研究纳入抗VEGF治疗至少5年后至少1次就诊时黄斑水肿消退的61眼(50例),按研究访视视力分为视力<20/40组24眼和≥20/40组37眼。视力较差组ELM和RPE带中断或缺失更常见(P=.003和P=.019),视网膜内层结构紊乱更普遍(P=.013),黄斑中心凹和旁中心凹外层视网膜厚度更薄(P=.022和P=.044)。多变量回归显示视力与RPE和ELM形态及外层视网膜厚度相关。
要点
- 抗VEGF长期治疗后DME消退眼中,ELM和RPE中断或缺失与视力较差相关。
- 视网膜内层结构紊乱在视力较差组更常见(P=.013)。
- 黄斑中心凹和旁中心凹外层视网膜变薄与视力较差相关。
核心结论
- 外层视网膜和RPE的改变是抗VEGF治疗DME眼长期视力结局的OCT生物标志物。
研究设计与样本
- 回顾性临床队列研究,纳入抗VEGF治疗开始后随访5年以上且至少1次研究访视时DME消退的61眼(50例患者)。
主要发现
- 视力<20/40组24眼,视力≥20/40组37眼;视力较差组ELM和RPE带中断或缺失更常见(P=.003和P=.019)。
- 视力较差组视网膜内层结构紊乱更普遍(P=.013)。
- 视力较差组黄斑中心凹和旁中心凹外层视网膜厚度更薄(P=.022和P=.044)。
- 多变量逐步线性回归显示视力与RPE和ELM形态相关(P<.0001和P=.048),与黄斑中心凹和旁中心凹外层视网膜厚度相关(P=.046和P=.035)。
关键数值与推荐
- 视力分组阈值:<20/40为视力较差/中等组,≥20/40为视力良好组。
临床怎么用
- 对长期抗VEGF治疗的DME患者,可通过OCT评估ELM、RPE完整性及外层视网膜厚度来辅助判断长期视力预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the morphological characteristics and long-term visual outcomes in eyes with diabetic retinopathy (DR) and diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (anti-VEGF) therapy. DESIGN: Retrospective clinical cohort study. METHODS: Patients with a long-term follow-up and evidence of resolved DME in at least 1 visit (study visit) after 5 years of follow-up after the initiation of anti-VEGF therapy were included. At the study visit, structural optical coherence tomography (OCT) scans were reviewed for qualitative features reflecting a distress of the neuroretina or retinal pigment epithelium (RPE). A quantitative topographical assessment of the inner and outer retinal thicknesses was also provided. RESULTS: A total of 61 eyes (50 patients) were included and were divided into 2 subgroups according to visual acuity (VA) at the study visit, yielding a group of 24 eyes with a VA <20/40 ("poor/intermediate vision" group), and 37 eyes with a VA ≥20/40 ("good vision" group). The external limiting membrane (ELM) and RPE bands were more frequently disrupted or absent in the poor/intermediate vision group (P = .003 and P = .019). Similarly, disorganization of retinal inner layers was more prevalent in the poor/intermediate vision group (P = .013). The foveal and parafoveal outer retinal thicknesses were reduced in eyes with poor/intermediate vision (P = .022 and P = .044). Multivariate stepwise linear regression analysis demonstrated that VA was associated with appearances of the RPE and ELM (P < .0001 and P = .048), foveal and parafoveal outer retinal thicknesses (P = .046 and P = .035). CONCLUSIONS: Modifications in the outer retina and RPE represent OCT biomarkers of long-term visual outcomes in eyes with DME treated with anti-VEGF.
引用
- Borrelli E, Grosso D, Barresi C, et al. Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy. Am J Ophthalmol. 2021. PMID: 34509431. doi:10.1016/j.ajo.2021.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。